ICCM Stock Analysis: Buy, Sell, or Hold?
ICCM - IceCure Medical Ltd. Ordinary Shares
$0.29
0.02 (5.89%)
▲
5d:
-1.92%
30d:
-4.98%
90d:
-53.57%
BUY
HIGH Confidence
Analysis Updated: Apr 30, 2026 12:00 AM ET
Earnings: May 27, 2026
25d
Get Alerted When ICCM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ICCM shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: ICCM shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: ICCM is currently trading at $0.29, which is considered slightly low relative to its 30-day fair value range of $0.26 to $0.48. From a valuation perspective, the stock is trading at a discount (Forward PE: -3.6) compared to its historical average (7.5). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ICCM is in a strong downtrend. Immediate support is located at $0.25, while resistance sits at $0.38. The stock is showing strong short-term momentum, up 5.9% recently.
Market Sentiment: ICCM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.73 (+852.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ICCM is in a strong downtrend. Immediate support is located at $0.25, while resistance sits at $0.38. The stock is showing strong short-term momentum, up 5.9% recently.
Market Sentiment: ICCM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.73 (+852.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.26 -
$0.48
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.9%)
- BULLISH: Trading 852.8% below Wall St target ($2.73)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$0.26 -
$0.48
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.25
Resistance Level
$0.38
Current Trend
Strong Downtrend
Technical data as of
Apr 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.57
Wall Street Target
$2.73
(+852.8%)
Revenue Growth (YoY)
46.2%
PE vs Historical
-3.6 vs 7.5
CHEAP
Share & Embed Analysis
Last updated: May 01, 2026 3:01 AM ET
Data refreshes hourly during market hours. Next update: 4:01 AM
Data refreshes hourly during market hours. Next update: 4:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICCM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$419 | 58 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$87 | 51 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 55 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$326 | 53 HOLD |
